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MicroRNAs (miRNAs) are small 21–22 nt RNAs that act to regulate the expression of
mRNA target genes through direct binding to mRNA targets. While miRNAs typically
dominate small RNA (sRNA) transcriptomes, many other classes are present including
tRNAs, snoRNAs, snRNAs, Y-RNAs, piRNAs, and siRNAs. Interactions between
processing machinery and targeting networks of these various sRNA classes remains
unclear, largely because these sRNAs are typically analyzed separately. Here, we present
TEsmall, a tool that allows for the simultaneous processing and analysis of sRNAs from
each annotated class in a single integrated workflow. The pipeline begins with raw fastq
reads and proceeds all the way to producing count tables formatted for differential
expression analysis. Several interactive charts are also produced to look at overall
distributions in length and annotation classes. We next applied the TEsmall pipeline
to sRNA libraries generated from melanoma cells responding to targeted inhibitors
of the MAPK pathway. Targeted oncogene inhibitors have emerged as way to tailor
cancer therapies to the particular mutations present in a given tumor. While these
targeted strategies are typically effective for short intervals, the emergence of resistance
is extremely common, limiting the effectiveness of single-agent therapeutics and driving
the need for a better understanding of resistance mechanisms. Using TEsmall, we
identified several microRNAs and other sRNA classes that are enriched in inhibitor
resistant melanoma cells in multiple melanoma cell lines and may be able to serve as
markers of resistant populations more generally.
Keywords: NGS software tools, small RNA and microRNA, transposon activity, melanoma, computational biology
INTRODUCTION
MicroRNAs (miRNAs) are small 21–22 nucleotide RNA molecules which have been shown to
play a critical role in metazoan development and gene regulation. While typically derived from
short hairpin RNA precursors located in both intergenic and intronic regions, miRNAs can also
be processed from other ncRNAs including tRNAs and spliced intron lariats (Schorn et al., 2017;
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Bartel, 2018). In addition to governing development, small RNAs
(sRNAs) play a critical role in repressing transcripts derived
from repetitive regions of the genome. In animals, siRNAs and
piRNAs function to repress transposons in somatic cells, and
the germline, respectively (Ghildiyal et al., 2008; Castañeda et al.,
2011). Identification of miRNAs and siRNAs which originate
from non-canonical regions of the genome is more challenging
with few programs designed to detect sRNAs from all classes
in both unique and repetitive genomic loci. It is for this
reason we present TEsmall, a package designed specifically for
the simultaneous analysis of sRNAs derived from a variety
of genomic features. In particular, this package facilitates the
discovery of intriguing biological phenomena otherwise masked
by insufficient annotation of repetitive genomic elements, such as
siRNAs, and allows these elements to be easily incorporated into
downstream differential analysis through packages like DESeq2
(Love et al., 2014).
We have tested the ability of TEsmall to characterize the
expression profiles of sRNAs from a variety of classes in
the context of melanoma cell lines responding to targeted
inhibitors of the BRAF oncogene. The genetic basis of melanoma
development is fairly well understood, with activating mutations
in the oncogene BRAF occurring in a majority of melanoma
patient tumors (Hodis et al., 2012), which also harbor hundreds of
secondary mutations of unknown impact. Specific inhibitors that
target activated BRAF as well as the downstream MAPK/ERK
signaling pathway have been developed, which dramatically
reduce the growth of melanoma cells in patients. However,
the effects of these drugs typically extend patient lifespan for
6 months or less, as the tumors rapidly develop resistance
to these targeted therapies (Villanueva et al., 2010). While
some tumors resistant to BRAF inhibitors acquire additional
genetic lesions that elevate MAPK or AKT signaling (Alcala
and Flaherty, 2012), many therapy-resistant cell lines establish
resistance without a clearly understood mechanism of resistance
(Gatenby and Brown, 2018). Changes to sRNA profiles in
melanoma cells responding to targeted inhibitors is an especially
poorly understood subset of the genomic and transcriptomic
changes that occur. To understand how sRNA alterations might
contribute to the development of resistance to BRAF inhibitors
in 451Lu melanoma cells that carry BRAFV600E mutations, we
undertook a sRNA sequencing study of cells before and after the
establishment of BRAF inhibitor resistance.
MATERIALS AND METHODS
Melanoma Cell Culture
In this dataset, 451 Lu patient derived melanoma cell lines
were used to explore the sRNA profiles of cells that are either
sensitive or resistant to small molecule inhibitors of the BRAF
kinase. Specifically, the melanoma patient derived 451Lu-Par cells
are grown in standard growth media (DMEM with 10% FBS),
while the 451Lu-BR cells are grown in standard growth medium
supplemented with a 1 µM concentration of the BRAF inhibitor
vemurafenib. Both cell lines are adherent cells grown in standard
2D cell culture. The derivation of BRAF inhibitor resistance in
these cells lines is described by Villanueva et al. (2010) and the
cell lines are available from Rockland for both 451Lu cells (cat:
451Lu-01-0001) and 451Lu-BR cells (cat: 451Lu BR-01-0001).
Small RNA Sequencing Libraries
Total RNA was extracted using the Ambion PureLink RNA
Mini Kit to extract up to 2 µg of total RNA from ∼1 × 10
(Hodis et al., 2012) melanoma cells from either the 451Lu-Par
or 451Lu-BR lines. Following Bioanalyzer verification of RIN
numbers at or above ∼9, the RNA extracts were next used to
create sRNA sequencing libraries. The sRNA sequencing libraries
were prepared with the Illumina TruSeq Small RNA Library
Preparation Kits using an input of 1.2µg total RNA and following
the manufacturer’s protocols as described, using 15 PCR cycles to
reduce the likelihood of PCR amplification artifacts. The libraries
were pooled and indexed with 6 nt Illumina barcodes, such that
six libraries could be sequenced per lane on an Illumina Genome
Analyzer IIx. The reads were sequenced as single-end 50 bp
reads, to a depth of approximately 35 million reads per library.
The dataset is available through GEO at the following accession
number: GSE116134. A table of sequenced and mapped read
counts for each library is presented in Supplementary File S1.
qPCR Validation
Taqman qPCR assays were used to validate the analysis
results of TEsmall for a subset of microRNAs. Specifically,
standard Taqman qPCR probes were obtained for the following
microRNAs: miR-100, miR-184, and miR-211. Control probes
were obtained for RNU58 and the U6 sRNA. Custom Taqman
probes were obtained for the predicted mature sequence of the
novel candidate miRtron derived from the VIM intron 6 locus.
The Taqman protocol was followed as described in the Thermo
Fisher Scientific TaqMan MicroRNA Assay protocol, available
from the manufacturer. Briefly, 10 ng of total RNA was used
as the input to a microRNA specific reverse transcription (RT)
assay using the TaqMan MicroRNA Reverse Transcription Kit
and an RT primer specific to the miRNA of interest. Next,
qPCR amplification was performed using 1.33 µL of the output
from the RT reaction, TaqMan Universal PCR Master Mix II
no UNG, and the TaqMan Small RNA Assay Kit specific to the
miRNA of interest. Each sRNA specific assay was performed
with input RNA from two biological replicates of the 451Lu-
Par and 451Lu-BR cell lines, with three technical replicates per
biological replicate, on a Thermo Fisher StepOnePlus Real-Time
PCR System. The “Comparative Ct” analysis method described in
the manufacturer’s protocol was used for calculating fold change,
standard deviation, and t-test based p-values. Briefly, the three
technical replicates for each probe were combined to create a
mean Ct value per probe per sample. The average of the Ct values
from the two control probes in each sample was then subtracted
from each microRNA Ct value to create a normalized “1-Ct”
value for each microRNA in each sample. Following averaging
of 1-Ct values between the two biological replicates in each
condition, the 1-1-Ct value was calculated as the difference in
mean 1-Ct values for the same microRNA across conditions.
Fold change represents 21−1−Ct , with errors on each Ct value
combined quadratically.
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TEsmall Module
TEsmall functions by accepting raw input in FASTQ file format
from next generation sequencing platforms in conjunction with
genomic annotation sets via an online server. Adapters associated
with siRNA library preparation are trimmed by TEsmall through
the cutadapt package (Martin, 2011). In order to remove
degradation products from abundant ribosomal RNAs, rRNA
derived reads are next filtered from the data before proceeding
to analysis. This mapping step allows for up to two mismatches
and filters a single alignment per read specified by the option:
bowtie -v 2 -k 1 using bowtie (v1.2.1) (Langmead, 2010). sRNA
reads remaining after rRNA filtering are then aligned more
stringently, disallowing mismatches, option: bowtie -v 0 -a -
m 100. All alignments in this step which map to fewer than
100 genomic loci are reported allowing for the classification
of multimapper reads common to sRNA data, in particular
structural RNAs like tRNAs and transposable element targeting
siRNAs. Following alignment to the genome, each alignment
is annotated via a sequential decision tree, as follows. The
alignments are distributed to each annotation category in order,
then removed from the pool of alignments in order to facilitate
priority annotation of, for example, intronic microRNA reads
that should properly be annotated as microRNAs rather than
intronic RNAs. The default order is: structural RNAs, miRNAs
and hairpins, exons, sense transposons, antisense transposons,
introns, and ultimately annotated piRNA clusters. This process
is depicted in Supplementary Figure S1. This annotation class
priority can be re-ordered by the user to suit the application
and user preferences. An HTML output file is then created using
python based Bokeh tools (Bokeh Development Team, 2014)
to visualize the abundance distributions, length distributions,
and mapping logs of all sRNAs in the dataset (Figure 1).
In conjunction with this HTML output, TEsmall compiles
multiple flat text output files, including a counts file that
is structured to be directly compatible with DESeq2 (Love
et al., 2014) for differential analysis. The abundance calculations
for these counts files are 1/n normalized at the end of this
annotation process, where n represents the number of alignments
per read, to ensure no double-counting of multimappers.
Additional packages employed within the TEsmall workflow
include bedtools (Quinlan and Hall, 2010), pandas (McKinney,
2010), samtools (Li et al., 2009), pybedtools (Dale et al., 2011),
and scipy (Jones et al., 2001).
The TEsmall code is available open-source from GitHub at the
following location: https://github.com/mhammell-laboratory/
tesmall.
Annotation files for the human (hg19) and fly (dm3) genomes
can be found at the following location: http://labshare.cshl.edu/
shares/mhammelllab/www-data/TEsmall/.
Instructions for creating annotation files for additional
genomes can be found in Supplementary File S4.
Differential Analysis With DESeq2
The counts file produced by TEsmall were subsequently imported
into DESeq2 (v1.18.1) to perform differential analysis between
451Lu-PAR and 451Lu-BR cell lines, as follows. The counts
file was filtered to remove low abundance species (<20
counts across all libraries) and increase the sensitivity of
DESeq2. Normalization of the counts for differential analysis
was performed using the default DESeq2 method during
FIGURE 1 | Flow chart and output HTML of TEsmall. (A) Flow chart of TEsmall’s treatment of input high-throughput sequencing data, input genome indices, and
output. (B) Screenshot of HTML output file for one sample. (C) Bar plot depicting size distribution of unique and multimapper reads. (D) Circle plot depicting
distribution of reads to each subtype. (E) Bar plot depicting proportion of subtypes across read length.
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statistical analysis. For downstream visualization, the counts were
normalized by the built-in variance stabilizing transformation
(VST) method in DESeq2. sRNAs with an adjusted p-value< 0.05
were considered statistically significant. The full DESeq2 output
file is given in Supplementary File S2.
Visualization
Figures were produced using the R packages ggplot2 (Wickham,
2009), gplots (Warnes et al., 2016) and GenomicRanges
(Lawrence et al., 2013) for scatterplots, heatmaps, and
wiggleplots, respectively. Python package matplotlib (Hunter,
2007) was used for all barplots. RNA secondary structures
were rendered using the forna webtool (Kerpedjiev et al.,
2015), secondary structure for the Arg-ACG-1-2 tRNA
was pulled from the UCSC GtRNAdb tRNA covariance
model, and structure of vimentin intron 6 was predicted
using RNAfold’s minimum free energy model (Gruber et al.,
2008).
RESULTS
TEsmall Workflow
TEsmall is a package specifically designed to identify sRNAs
derived from a variety of genomic features simultaneously, such
that users can evaluate the relative abundances and profiles
of many source of sRNAs on a common scale in a single
pipeline. This serves as a novel improvement to currently
available software such as mirDeep2 (Friedländer et al., 2012)
and piPipes (Han et al., 2015), which are optimized for the
analysis of miRNAs and piRNAs, respectively, but are not
equipped to evaluate both types of sRNAs together. TEsmall
is also designed so that its output is optimally formatted
for downstream differential analysis with statistical modeling
software, such as DEseq2 (Anders and Huber, 2010). A flowchart
describing the entire TEsmall workflow is given in Figure 1A,
with example output charts given in Figures 1B–E. Specifically,
in the first module of TEsmall, raw sRNA sequencing reads
from Illumina NGS sequencing platforms serve as the input
without the need to pre-process the data before beginning
analysis. TEsmall first trims adapter contaminants from the
reads and then filters the reads for appropriate size ranges,
with a default of 16–36 nucleotides in length. The next
module of TEsmall removes contaminating ribosomal RNA
fragments by mapping with bowtie (Langmead, 2010) to a
library of rRNAs for the specified genome. Removal of rRNA
reads is critical as rRNA degradation products are a major
source of contamination for sRNA data. Remaining reads
are mapped to the genome, with a default mapping strategy
optimized for repetitive regions with up to 100 alignments
per read, though this may be altered by the user. The reads
are next sequentially annotated to several sRNA classes and
genomic features, with a decision tree implemented to prioritize
annotation categories. This has the goal of attributing reads
mapping to intronic microRNAs as “microRNA” reads, for
example, rather than annotating these reads as having an
intronic source. Following annotation of each read, aggregate
abundances are calculated for each sequencing library and
outputted as a counts table suitable for downstream differential
expression analysis. Importantly, any multimapper reads in
these counts tables are weighted according to the number
of genomic loci from which they derive (1/n where n is
the number of alignments) to avoid any double-counting of
multimapper reads in the counts tables. In addition to an
output file including all raw count data per sample, RNA
species ID, and type classification, TEsmall provides an aesthetic
output HTML (Figure 1B) summarizing distribution of read
lengths (Figure 1C), proportion of reads assigned to each
sRNA type (Figure 1D), and distribution of reads of a
particular size to each of the sRNA categories (Figure 1E).
In addition to these summary plots, TEsmall presents a
table with summary statistics of read proportion, raw input
and trimmed read counts to quickly assess any potential
biases in library preparation that may affect downstream
normalization.
Application of TEsmall to Melanoma
sRNA Profiles
As described, drug resistance is a known hurdle in the treatment
of melanoma, driving the need for a better understanding of
how cells develop resistance. We have chosen to investigate
the alterations in sRNA profiles, as one marker of cellular
state. To investigate the effect of BRAF kinase drug resistance
on sRNA composition in patient derived melanoma cell
lines, we performed differential expression analysis following
classification by TEsmall in two biological replicates of parental
and BRAF inhibitor resistant cell lines. Resistant lines were
derived through exposure of 451Lu patient derived parental
cell lines to increasing concentrations of vemurafenib up
to 1 µM. Resistant clones were selected and expanded
before exposure to an increase in vemurafenib. Cells were
otherwise treated as described in Villanueva et al. (2010)
Raw count data was normalized as described in Materials
and Methods by DESeq2. All VST normalized counts were
averaged between parental or resistant replicates and plotted
against each other to visualize trends of expression across
sRNA subtypes without filtering for significant or abundant
transcripts, significantly differentially expressed transcripts are
represented by solid coloring (Figure 2). Overall, there appears
to be a trend toward lower expression of many sRNA classes
in the 451Lu BRAF resistant samples, with more down-
regulated than up-regulated species for most classes of sRNAs
(Figures 2, 3B). However, upon testing by a two tailed Welch’s
t-test only structural RNAs were shown to be significantly
downregulated as a class in BRAF inhibitor resistant libraries
(P < 3.52 × 10−13). Upon filtering for the most abundant
(base mean across all replicates > 500) and significantly
differentially expressed transcripts (multiple-hypothesis testing
adjusted p-value < 0.05), trends of lower sRNA expression in
the BRAF resistant samples was still seen for many intronic,
exonic, and transposon mapped sRNA species (Figure 3).
Interestingly, miRNAs show an even distribution of species
with negative and positive log fold changes, and since miRNAs
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FIGURE 2 | Scatterplots depicting 451Lu BRAF resistant versus parental RNA: VST normalized counts. (A) Overlay of all subtype scatterplots. (B) RNA subtype
specific scatterplots. Transparent points represent RNA species with adjusted p-value < 0.05.
FIGURE 3 | Differential expression analysis of highly abundant sRNAs. (A) Heatmaps depicting all significantly differentially expressed sRNAs per subtype. All
heatmaps are row-scaled to lie between –1 and 1, based on the VST normalized count values. P1, P2, R1, and R2 represent 451Lu parental replicates 1 and 2 and
451Lu BRAF Resistant replicates 1 and 2, respectively. (B) Bar plot depicting number of abundant and significantly differentially expressed species with a negative or
positive log fold change per subtype. Structural RNA species are collapsed for duplicate tRNAs.
were the most abundantly sequenced sRNAs in the libraries,
this rules out a normalization issue as the explanation for
down-regulated sRNAs in the other classes. It may be of
interest that, after filtering for significance (P < 0.05) and
abundances greater than 500 reads per million mapped (RPM),
structural RNAs with a negative log fold change are almost
exclusively tRNAs and those with a positive log fold change
are almost exclusively snoRNAs. Details of the particular sRNAs
differentially expressed in each of these classes are given in
Supplementary File S2.
Type Specific Analysis of sRNA Species
and Validation With qPCR
Several miRNAs which are significantly differentially expressed
in our dataset have been previously described in the literature
Frontiers in Genetics | www.frontiersin.org 5 October 2018 | Volume 9 | Article 461
fgene-09-00461 October 3, 2018 Time: 19:14 # 6
O’Neill et al. TEsmall sRNAs in Melanoma
as playing critical roles in melanoma progression or epidermal
differentiation. This includes the miRNAs miR-184, miR-211,
and miR-100. In other contexts, miR-184 has been shown to
arrest epidermal differentiation through de-repression of Notch
in normal human keratinocytes and murine epidermis (Nagosa
et al., 2017). While expression of Notch in keratinocytes is
known to have a tumor suppressive phenotype, its expression
has the opposite effect in melanocytes through upregulation of
the PI3K/Akt and MAPK pathways (Pinnix and Herlyn, 2007).
Our data showed an approximate fivefold increase in miR-184
expression in BRAF inhibitor resistant cells relative to parental
(Figure 4A and Supplementary File S2), consistent with a
model where MAPK pathway activation provides a mechanism
for BRAF inhibitor resistance (Villanueva et al., 2010, 2011).
It has also been shown that BRAF inhibitor resistance can
be mediated by regulatory escape of the transcription factor
MITF from the MAPK pathway, where MITF overexpression
itself conferred resistance in several melanoma cell lines (Van
Allen et al., 2014). Consistent with a high MITF state, our
data shows a significant upregulation of miR-211, derived
from the MITF activated gene melastatin, and a significant
downregulation of miR-222, known to be inversely correlated
with MITF expression (Golan et al., 2015). Finally, miR-100 was
also shown to be significantly downregulated in our data; this
was a miRNA of interest as it has been implicated in prostate
cancer as a repressor of the oncogene mTOR (Leite et al.,
2013).
To validate the expression profiles from our TEsmall based
differential expression analysis, we performed qPCR on several
miRNAs of interest including miRNAs miR-184, miR-211, and
miR-100, all of which recapitulated the trend observed in our
sRNA-seq dataset (Figure 4A). Reassuringly, the expression
alterations of miR-204 and miR-211 seen in our data were also
seen in an alternative melanoma derived cell line A375 in Díaz-
Martínez et al. (2018) following induction of BRAF inhibitor
resistance.
Upon further investigation into individual RNA species from
different subtypes for follow up, we encountered an interesting
and novel 21 nucleotide sRNA derived from the sixth intron
in the vimentin gene (VIM) (Figure 4B). Intronic microRNAs
can either derive from their own precursor transcripts dubbed
pri-miRNAs or can alternately derive from short spliced introns
with internal hairpin structures dubbed miRtrons (Okamura
et al., 2007). MiRtrons are typically generated via the splicing
machinery from short introns (∼100 nt) and subsequently
processed by DICER in the cytoplasm, bypassing the canonical
nuclear DROSHA processing steps. This is in contrast to
intronically located miRNAs that derive from their own
precursor pri-miRNAs and are dependent upon both DROSHA
and DICER for processing. As visible in the minimum free
energy secondary structure prediction by RNAfold, the candidate
miRNA of interest is located in a stem loop structure which
appears conducive to processing by DICER (Figure 4C). The
length of this mature sRNA (21 nt), the short length of its host
intron (350 nt), its abundance as a single RNA species, and its
secondary structure within VIM intron 6 could all be consistent
with a miRNA derived from either an intronic pri-miRNA or as
a miRtron. This is particularly interesting as VIM is a known
marker for the epithelial to mesenchymal transition and is well
expressed in many cell types, but has not previously been shown
to harbor a miRNA, suggesting this candidate VIM miRNA might
represent a novel sRNA with particular abundance in melanoma
cells.
In addition to miRNAs, TEsmall recognizes several other types
of sRNAs. It has been previously reported that tRNA derived
sRNA molecules (tRFs) can silence LTR retrotransposable
elements through occupation of the primer binding site (PBS)
as an adaptation of the role of tRNAs as retroviral primers
(Mak and Kleiman, 1997; Schorn et al., 2017). Through
TEsmall, one is able to detect reads associated with tRNAs
and transposable elements in the same pipeline facilitating
observation of phenomena such as these. In our analysis,
several species of sRNAs mapping antisense to transposable
elements were significantly depleted in BRAF resistant cell lines
compared to parental (Figure 2). Upon further investigation
we were able to determine that a subset of these reads
FIGURE 4 | Detailed analysis miRNAs of interest. (A) qPCR representing fold change of miRNAs miR-184, miR-211, and miR-100 in 451Lu BRAF Resistant samples
relative to 451Lu parental expression levels across replicates. (B) qPCR representing log fold change of the VIM miRNA in 451Lu BRAF Resistant vs. Parental
samples and BAM gene alignment tracks across samples. (C) RNAfold predicted secondary structure of VIM intron 6 with the candidate miRNA highlighted in purple.
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FIGURE 5 | tRNA and TE interaction through primer binding sites. (A) Diagram of primer binding by tRNA to facilitate retroviral reverse transcription. (B) Read
alignment track of Arg-CGY family derived 18 nt CCA tailed fragment to HERV30 PBS. (C) Consensus histogram of reads distributed from Arg-CGY tRNAs, and
derived 3′ tRFs. (D) Secondary structure of Arg-CGY family member Arg-ACG-1-2 with highlighted 15 nt CCA (-) fragment.
were tRFs derived from the Arg-CGY family of tRNAs
(Figure 5B). These candidate tRFs mapped to a subset of
HERVs including HERV3, HERV30, MER51, and others (see
Supplementary File S3). This is consistent with previous
literature showing HERV-R type retrotransposons are primed
by Arg tRNAs (Figure 5A) and that tRNA derived fragments
can occupy retroviral PBSs to suppress transposon activity
(Mak and Kleiman, 1997; Schorn et al., 2017). It is important
to note that the Arg-CGY sRNAs reported by TEsmall are
consistent with the tRFs previously described in Schorn et al.
(2017) as they are 18 nt CCA-appended fragments originating
from the 3′ T-arm of tRNAs. This is shown graphically in
Figure 5, where the pileup of reads at an example HERV
PBS locus can be seen in Figure 5B, and the pileup of
these same reads at the originating tRNA locus can be seen
Figures 5C,D. In the tRNA profiles, other tRNA fragments
including tRNA derived stress-induced RNAs (tiRNAs) can
be seen outside of the tRF generating 3′ end, but these do
not predominantly accumulate as a single abundant sRNA
species.
In addition to the miRNAs and tRFs highlighted above,
several additional species of sRNAs were reported by TEsmall
as differentially expressed in the 451Lu BR cells including:
siRNAs mapping to transposable element loci, exonic loci, and
a variety of structural RNA classes. The structural RNA group
included snoRNAs, snRNAs, tRNA fragments, and a vault RNA.
The full list of differentially expressed sRNAs can be found in
Supplementary File S2.
Comparison of TEsmall With sRNA
Analysis Software
Several software packages exist to characterize sRNA data for
expression profiling analysis. However, programs designed for
this purpose such as miRDeep2 (Friedländer et al., 2012),
ShortStack (Axtell, 2013), Chimira (Vitsios and Enright, 2015),
sRNAtoolbox (Rueda et al., 2015), and Oasis 2 (Rahman
et al., 2018) typically focus on a particular category of sRNA,
predominantly miRNAs. Several packages also consider multiple
sRNA types including piPipes (Han et al., 2015), omiRas (Müller
et al., 2013), and unitas (Gebert et al., 2017) which include
analysis of other non-coding RNAs. However, the output formats
of these packages do not lend themselves to easy application
of statistical analysis tools like DEseq2 for downstream use
Frontiers in Genetics | www.frontiersin.org 7 October 2018 | Volume 9 | Article 461
fgene-09-00461 October 3, 2018 Time: 19:14 # 8
O’Neill et al. TEsmall sRNAs in Melanoma
and manipulation. While piPipes functions well to annotate
and characterize piRNAs by read pileups associated with the
ping-pong cycle of piRNAs, it is not particularly suited for
annotation of sRNAs from other types of genomic loci, such
as miRNAs, siRNAs, and tRFs. PiPipes provides plots of read
distribution across lists of transposable elements and piRNA
clusters, however, one cannot access tables of these counts with
associated TE annotation, suitable for differential expression
analysis. While piRNAs are annotated with their respective
piRNA clusters, siRNAs are assigned a chromosomal coordinate
providing some difficulty in determining patterns in the sources
or targets of these reads. It is also of import that intron
derived miRNAs like the VIM miRtron were not captured,
as there is no mechanism by which to assign siRNA reads
beyond mapping the chromosomal coordinates associated to
preloaded annotation sets associated with TEs and piRNA
clusters. TEsmall, which does not perform piRNA-specific
ping-pong analysis, provides a complementary package that is
designed to be a general purpose sRNA analysis suite to identify
and analyze many types of sRNAs concurrently, presenting
the output in a format intended for expression profiling
analysis. As piPipes output was not directly comparable to
TEsmall output, we performed quantitative comparisons between
TEsmall and miRDeep2 output, as seen in Supplementary
Figure S2. TEsmall and miRDeep2 preformed comparably
with differences originating from higher stringency in TEsmall
annotation. This stringency caused fewer reads to be mapped to
miRNAs by the TEsmall pipeline. Some reads were attributed
by TEsmall to rRNAs and discarded, while others were not
attributed to the respective miRNA loci due to mismatched
nucleotides within the miRNA. Users interested in the possibility
of A-I editing, or other sources of mismatched alignments,
may optionally choose to allow mismatches during TEsmall
alignment to capture these reads. Output of TEsmall and
miRDeep2 annotation was found to be highly comparable
with Pearson correlation coefficients of DEseq2 normalized
miRNA counts between parental and resistant libraries of
0.882 and 0.910, respectively. Following differential expression
analysis by DEseq2 of the TEsmall and miRDeep2 outputs,
the Pearson correlation coefficient of log2 fold change values
was 0.867. Finally, the novel VIM-encoded miRNA was not
captured in the miRDeep2 output. This analysis supports
TEsmall as comparable to class-specific sRNA expression analysis
packages, while providing information on a wider source of
sRNAs.
DISCUSSION
TEsmall is a software package with novel functionality in
that it allows the user to simultaneously map and annotate
many types of sRNAs including structural RNAs, miRNAs,
siRNAs, and piRNAs. This allows one to compare trends in
expression between all sRNA types and investigate the cross-
talk between distinct sRNA regulatory pathways. Other packages
released to date focus on individual sRNA types like miRNAs
(Friedländer et al., 2012; Axtell, 2013) or piRNAs (Han et al.,
2015) and while optimized for these applications, are not
adapted for comparison across sRNA categories. In addition
to handling multiple classes of sRNAs, the output of TEsmall
is formatted for direct integration into downstream analysis
pipelines. TEsmall’s output files are compatible with statistical
analysis software like DESeq2 and efficient heatmap generation.
In addition to requiring little data preprocessing, TEsmall
outputs an aesthetic HTML file of charts (Figure 1B) which
allows for fast and effortless assessment of library quality,
sRNA composition, and size distribution. TEsmall can also be
expanded to function for any novel sRNA species provided
the appropriate annotation files are available, allowing it to
serve as a powerful tool to study RNA biology in many
organisms.
We applied TEsmall to a novel dataset in which we compared
the effects of BRAF inhibitor resistance on sRNA abundance
in melanoma derived cell lines. In this analysis, we found
several microRNAs whose expression was altered in BRAF
inhibitor resistant cells in comparison to parental lines.
A table of these hits can be found in Supplementary File
S2. Among these candidates, we experimentally validated
changes in expression of miRNAs miR-184, -211, and -100.
Of particular interest is the novel Vimentin derived miRtron
candidate, whose expression pattern was also experimentally
validated. Close examination of the characteristic read pile up
associated with the VIM miRtron, and secondary structure of
intron 6 are all consistent with miRtron processing pathways.
Further investigation will be required to determine if this is
a true miRtron formed through an intermediate spliceosome
derived lariat independent of the Drosha microprocessor
subunit, or is instead a canonical Drosha-dependent
miRNA.
In addition to revealing miRNAs previously described in
the literature, TEsmall detected several novel classes of sRNAs
which would not have been found using packages designed for
miRNA analysis. TEsmall allows the user to investigate tRNA
derived fragments which have been shown to play a critical
role in LTR retro-transposon suppression (Schorn et al., 2017).
In the melanoma dataset, we identified a novel candidate tRF
that appears to derive from ARG-tRNAs and to potentially
regulate several HERV-R type LTR elements through occupancy
of the PBS. Other types of siRNAs that regulate transposon
expression were also shown to be differentially expressed
in these datasets, suggesting the possibility that transposon-
derived transcripts are altered in these BRAF inhibitor resistant
melanoma cells.
It is well known that small non-coding RNAs of
different subtypes types work in conjunction to regulate
cellular processes through complex networks, particularly
in the realm of transposon silencing. piRNAs known to
regulate transposon expression in the germline have been
found to work in cooperation with siRNAs to perform
this task (Tam et al., 2008). In plants, miRNAs have
been shown to play a role in transposon silencing by
serving as an intermediate to form 21 nucleotide siRNAs
via RNA dependent RNA polymerase and while the
mechanism would be disparate from plants, hints of miRNAs
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facilitating transposon silencing have been seen in animals
as endogenous and introduced retroviral elements with
homologous regions to miRNAs have lower genomic activity
(Hakim et al., 2008; Zlotorynski, 2014). Current sRNA analysis
packages are specific to one or two types of sRNAs making it
easy to overlook biologically interesting patterns of interaction
between sRNA classes. For this reason, we have created
TEsmall, an easy to use package with aesthetic output designed
for the concurrent expression analysis of multiple sRNA
subtypes.
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FIGURE S1 | Flow chart of the default sequential decision tree used by TEsmall to
assign annotations. Alignments are assigned to each category in the indicated
order and, if annotated, are removed from the pool before preceding to the next
annotation category. Users may opt to re-order the priority table.
FIGURE S2 | Scatterplots comparing TEsmall and miRDeep2 miRNA abundance
quantification. Mean abundances between biological replicates (A,B) and fold
change between conditions (C) were calculated with DEseq2 on the count tables
output by each software package. Low abundance miRNAs with fewer than 2,000
counts across all samples are marked as transparent. Shown in pink are the
miRNAs validated by qPCR in Figure 4. (A) Log scaled comparison of 451Lu-Par
normalized miRNA counts of TEsmall versus miRDeep2, with a correlation
coefficient of r = 0.882. (B) Log scaled comparison of 451Lu-BR miRNA counts of
TEsmall versus miRDeep2, with a correlation coefficient of r = 0.910.
(C) Comparison of log2 fold change as reported by TEsmall and miRDeep2, with a
correlation coefficient of r = 0.867.
FILE S1 | Table of library composition and mapping rates across all replicate small
RNA libraries.
FILE S2 | Table including the raw output from DEseq2 and several worksheets of
filtered differentially expressed sRNAs used in constructing the heatmaps in
Figure 3.
FILE S3 | List of long terminal repeat flanked transposable elements mapped to
the Arg-ACG 3′ tRF and their chromosomal start site in the hg19 genome.
FILE S4 | Instructions for creating new annotation files for additional species.
Instructions for customizing the path for stored annotation files.
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